Business Description
Par Drugs and Chemicals Ltd
ISIN : INE04LG01015
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.82 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 13.3 | |||||
Beneish M-Score | -2.55 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 20 | |||||
3-Year EBITDA Growth Rate | 24.4 | |||||
3-Year EPS without NRI Growth Rate | 33.3 | |||||
3-Year FCF Growth Rate | -2.2 | |||||
3-Year Book Growth Rate | 20.6 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 27.07 | |||||
9-Day RSI | 36.5 | |||||
14-Day RSI | 43.76 | |||||
6-1 Month Momentum % | 6.89 | |||||
12-1 Month Momentum % | 45.17 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.06 | |||||
Quick Ratio | 3.75 | |||||
Cash Ratio | 2.24 | |||||
Days Inventory | 27.89 | |||||
Days Sales Outstanding | 70.84 | |||||
Days Payable | 51.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 36.43 | |||||
Operating Margin % | 18.93 | |||||
Net Margin % | 14.72 | |||||
FCF Margin % | 5.94 | |||||
ROE % | 19.79 | |||||
ROA % | 15.84 | |||||
ROIC % | 24.07 | |||||
ROC (Joel Greenblatt) % | 36.13 | |||||
ROCE % | 24.97 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 22.24 | |||||
PE Ratio without NRI | 22.44 | |||||
Price-to-Owner-Earnings | 28.45 | |||||
PEG Ratio | 1 | |||||
PS Ratio | 3.27 | |||||
PB Ratio | 4.03 | |||||
Price-to-Tangible-Book | 3.87 | |||||
Price-to-Free-Cash-Flow | 55.09 | |||||
Price-to-Operating-Cash-Flow | 23.65 | |||||
EV-to-EBIT | 14.49 | |||||
EV-to-EBITDA | 12.28 | |||||
EV-to-Revenue | 2.83 | |||||
EV-to-FCF | 49.89 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.21 | |||||
Price-to-Graham-Number | 2.04 | |||||
Price-to-Net-Current-Asset-Value | 8.22 | |||||
Price-to-Net-Cash | 23.75 | |||||
Earnings Yield (Greenblatt) % | 6.91 | |||||
FCF Yield % | 1.9 | |||||
Forward Rate of Return (Yacktman) % | 21.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Par Drugs and Chemicals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 966.59 | ||
EPS (TTM) (₹) | 11.56 | ||
Beta | 1.07 | ||
Volatility % | 35.26 | ||
14-Day RSI | 43.76 | ||
14-Day ATR (₹) | 16.05501 | ||
20-Day SMA (₹) | 269.6825 | ||
12-1 Month Momentum % | 45.17 | ||
52-Week Range (₹) | 169.05 - 325 | ||
Shares Outstanding (Mil) | 12.3 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Par Drugs and Chemicals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Par Drugs and Chemicals Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Par Drugs and Chemicals Ltd Frequently Asked Questions
What is Par Drugs and Chemicals Ltd(NSE:PAR)'s stock price today?
When is next earnings date of Par Drugs and Chemicals Ltd(NSE:PAR)?
Does Par Drugs and Chemicals Ltd(NSE:PAR) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |